HBCU-Pharma Project Will Create Clinical Trial Centers of Excellence
July 1, 2022 at 01:15 PM EST
Novartis committed $17.7 million to create Clinical Trial Centers of Excellence at three Historically Black Colleges and Universities (HBCUs) as part of the 10-year, $50 million Beacon of Hope collaboration with 26 HBCUs and Medical Schools, the Thurgood Marshall College Fund (TMCF), Coursera and the National Medical Association.
Novartis and the Novartis US Foundation are wo... Read More
